Cutia Therapeutics (HK:2487) has released an update. Cutia Therapeutics’ CEO, Ms. Zhang Lele, has further increased her stake in the ...
Cutia Therapeutics (HK:2487) has released an update. Cutia Therapeutics has announced the completion of a Phase II clinical trial for CU-20401, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback